These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22706853)

  • 21. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aims.
    Davis BH; Wood B; Oldaker T; Barnett D
    Cytometry B Clin Cytom; 2013; 84(5):282-5. PubMed ID: 24022850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporary Regulatory Deviations and the Coronavirus Disease 2019 (COVID-19) PCR Labeling Update Study Indicate What Laboratory-Developed Test Regulation by the US Food and Drug Administration (FDA) Could Look Like.
    Marble HD; Bard AZ; Mizrachi MM; Lennerz JK
    J Mol Diagn; 2021 Oct; 23(10):1207-1217. PubMed ID: 34538703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory compliance for point-of-care testing. A perspective from the United States (Circa 2000).
    Lee-Lewandrowski E; Lewandrowski K
    Clin Lab Med; 2001 Jun; 21(2):241-53, vii. PubMed ID: 11396081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pathology Laboratory Act 2007 explained.
    Looi LM
    Malays J Pathol; 2008 Jun; 30(1):1-10. PubMed ID: 19108405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical laboratory improvement amendments (CLIA) of 1988. Here are answers to your most frequently asked questions.
    Wolff T
    Mich Med; 1993 Mar; 92(3):45-7. PubMed ID: 8231915
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory-Developed Tests: Design of a Regulatory Strategy in Compliance with the International State-of-the-Art and the Regulation (EU) 2017/746 (EU IVDR [In Vitro Diagnostic Medical Device Regulation]).
    Spitzenberger F; Patel J; Gebuhr I; Kruttwig K; Safi A; Meisel C
    Ther Innov Regul Sci; 2022 Jan; 56(1):47-64. PubMed ID: 34291407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current regulatory issues in cell and tissue therapy.
    Burger SR
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preproduction quality assurance: quality intrinsic to design.
    Hudson BJ
    Med Des Mater; 1991 Apr; 1(4):34-40. PubMed ID: 10147993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCFA report card: where CLIA (Clinical Laboratory Improvement Amendments of 1988) stands.
    Albertson D
    MLO Med Lab Obs; 1994 Dec; 26(12):16-7. PubMed ID: 10139357
    [No Abstract]   [Full Text] [Related]  

  • 30. Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule.
    Centers for Disease Control and Prevention (CDC) (2) Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Jan; 68(16):3639-714. PubMed ID: 12545998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the regulatory requirements for dialysate.
    Ward RA
    Nephrol News Issues; 1991 Jan; 5(1):13, 15. PubMed ID: 1961262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Final rule.
    Fed Regist; 1998 May; 63(93):26722-38. PubMed ID: 10179342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trying to improve their image. But FDA scanning hearing reveals regulatory void.
    Rhea S
    Mod Healthc; 2010 Apr; 40(14):14. PubMed ID: 20405553
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ideas and Briefing about Regulatory Requirements for Laboratory Developed Tests in the US].
    Han Z; Zhao Y; L Y; Dong J; Deng G
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Sep; 46(5):534-537. PubMed ID: 36254482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complexity of compliance in IVD manufacturing.
    Lokas K
    Med Device Technol; 2005 Dec; 16(10):26-7. PubMed ID: 16419923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food and Drug Administration regulation of in vitro diagnostic devices.
    Mansfield E; O'Leary TJ; Gutman SI
    J Mol Diagn; 2005 Feb; 7(1):2-7. PubMed ID: 15681468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostics Reform and Harmonization of Clinical Laboratory Testing.
    Schreier J; Feeney R; Keeling P
    J Mol Diagn; 2019 Sep; 21(5):737-745. PubMed ID: 31075512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA's proposed rule for the regulation of laboratory-developed tests.
    Miller MB; Watts ML; Samuel L
    J Clin Microbiol; 2024 Feb; 62(2):e0148823. PubMed ID: 38206042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point-Counterpoint: The FDA Has a Role in Regulation of Laboratory-Developed Tests.
    Caliendo AM; Hanson KE
    J Clin Microbiol; 2016 Apr; 54(4):829-33. PubMed ID: 26791369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empowering microarrays in the regulatory setting.
    Casciano DA; Woodcock J
    Nat Biotechnol; 2006 Sep; 24(9):1103. PubMed ID: 16964221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.